Harm Reduction Therapeutics

About Harm Reduction Therapeutics

Harm Reduction Therapeutics, Inc. (HRT) is a non-profit pharmaceutical company focused on saving lives by providing accessible, compassionate care through their over-the-counter (OTC) naloxone product, RiVive. Their mission is rooted in empathy, valuing every life, and ensuring help is within reach for those at risk of opioid overdose. They aim to reduce the inherent risks associated with substance use and help people stay alive.

Products & Services

RiVive Naloxone HCI Nasal Spray 3 mg:An FDA-approved over-the-counter naloxone nasal spray for emergency treatment of opioid overdose, including heroin and fentanyl. It is the lowest dose of OTC intranasal naloxone available in the U.S., designed to reduce the risk of precipitated withdrawal while effectively saving lives with Compassionate Overdose Response™. Manufactured in the United States and sold at cost with zero profit.

Specialties

Harm Reduction Opioid Overdose Reversal Compassionate Care Naloxone Development and Distribution

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Additional Financial Support T: - FT: Additional Financial Support	A: 9000000 MR: - FA: $9 million FAN: 9000000	D: 2023-03-21 FD: 2023-03-21	1 investors

Additional Financial Support Latest

2023-03-21

$9.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

John Pinney

Co-Founder & Chairman of the Board

LinkedIn (Pro only)

M

Michael R. Hufford

Co-Founder & Chief Executive Officer

LinkedIn (Pro only)

V

Van Asher

Sales & Harm Reduction Specialist

C

Catey Galatola Tetro

Director of Sales & Marketing

J

Judy Ashworth

Chief Medical Officer

J

James E. Kelly

President & General Manager

View 8 more team members with Pro

Unlock Full Team Directory

Recent News